- Jun 13, 2018
So what you're saying is the ifs have it...Honestly, all the reports at this points are anecdotal at best. There's not nearly enough data re: testing, etc. to draw conclusions about the current situation as it relates to the B.1.167 variant. So far, the breakthrough infections are largely related to the AstraZeneca vaccine (prominent in India), which has been less effective generally against variants (including B.1.1.7 or the "British" variant, which is also likely a contributor to the current wave in India). Then there's the broader social context to consider - single digit vaccination rates, general population sentiments re: crowds and distancing, etc.
TL;DR - wait for more data, the story is likely much more complex than a single variant.